Expression vectors market is expected to experience growth due to factors such as rise in demand for biologics (protein -based drugs), increase in infectious diseases and genetic disorders. Expression vector is also called as expression construct. It is a plasmid or virus which is used in expression of protein in various types of host cells. The expression vector assists the gene of interest to introduce itself into target call and helps mechanism of cell to produce the protein which is encoded by the gene.
Expression vectors has characteristics such as origin of replication, selectable marker and site of insertion of gene. Applications of protein expression vectors are large scale production of human insulin and other protein -based products. Expression vectors are also used in molecular biology, genetics and computer science.
COVID-19 scenario analysis:
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunity for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. Owing to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future. Considering these factors, Covid -19 is expected to have significant impact on Expression Vectors Market.
Top Impacting factors:
- Factors such as rise in demand for biologics and increase in prevalence of infectious and genetic disease is expected to boost the growth of expression vectors market.
- Advancements made in the techniques of protein expression and new technologies in the genetics, bioinformatics and molecular biology is driving the expression vector market growth.
- Insulin production at a large scale and demand for other protein- based products which are used in expression vectors are expected to rise the expression vectors market growth.
- Restraining factors such as high costs involved in research of expression vectors is lowering the growth of expression vectors market. Increasing competition among the market players in expected to hamper the market growth.
New Product Launch / News:
- In June 2019, Krystal Biotech announced that they have got positive results from Phase II clinical trial of KB103 which is a gene therapy. It has also received the regenerative medicine advanced therapy designation for KB103 from FDA. KB103 would help to treat dystrophic epidermolysis bullosa, which is a rare and incurable form of epidermolysis bullosa (EB)
Key benefits of the report:
- This study presents the analytical depiction of the Global Expression Vectors Market along with the current trends and future estimations to determine the investments.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the Expression Vectors Market share.
- The current market is quantitatively analyzed to highlight the Expression Vectors Market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed Expression Vectors Market analysis based on competitive intensity and how the competition will take shape in coming years.
Questions answered in the Expression Vectors Market Report:
- What are the leading market players active in Expression Vectors Market?
- What the current trends will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities in the market?
- What are the projections for the future that would help in taking further strategic steps?
- What Segments and region will drive the market growth & why?
Expression Vectors Market Report Highlights
| Aspects | Details |
 By Host type |
|
 By Application |
|
 By End User |
|
 By Region |
|
 Key Market Players | Clontech Laboratories, Inc., Promega Corporation, Thermo Fisher Scientific Inc., Agilent Technologies, Bio-Rad Laboratories, DNA2.0, New England Biolabs., Merck Millipore, GenScript USA, Sigma-Aldrich Corporation |
Loading Table Of Content...
